Lenvatinib in Locally Advanced Invasive Thyroid Cancer

NCT04321954 PHASE2 ACTIVE_NOT_RECRUITING

This research is being done to evaluate the safety and efficacy of neoadjuvant lenvatinib on surgical outcomes of patients with invasive extrathyroidal differentiated thyroid cancer (DTC). This research study involves a study drug called lenvatinib

Details

Lead sponsor	Massachusetts Eye and Ear Infirmary
Phase	PHASE2
Status	ACTIVE_NOT_RECRUITING
Enrolment	30
Start date	Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed May 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Differentiated Thyroid Cancer
• Advanced Cancer

Interventions

• LENVATINIB

Countries

United States